IBRX earnings
ImmunityBio (IBRX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
IBRX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 4, 2026 | -0.22 | -0.08 | -175.00% | $51.24M |
| Q1 2026 | May 7, 2026 | -0.62 | -0.08 | -675.00% | $44.21M |
| Q4 2025 | Feb 23, 2026 | -0.06 | -0.08 | 25.00% | $38.28M |
| Q3 2025 | Nov 4, 2025 | -0.07 | -0.10 | 30.00% | $32.06M |
| Q2 2025 | Aug 5, 2025 | -0.10 | -0.10 | 0.00% | $26.43M |
| Q1 2025 | May 12, 2025 | -0.15 | -0.12 | -25.00% | $16.52M |
| Q4 2024 | Mar 3, 2025 | -0.09 | -0.26 | 65.38% | $7.55M |
| Q3 2024 | Nov 12, 2024 | -0.14 | -0.18 | 22.22% | $6.11M |
| Q2 2024 | Aug 12, 2024 | -0.20 | -0.17 | -17.65% | $1.05M |
| Q1 2024 | May 9, 2024 | -0.20 | -0.16 | -25.00% | $40.00K |
| Q4 2023 | Mar 18, 2024 | -0.36 | -0.18 | -100.00% | $139.00K |
| Q3 2023 | Nov 8, 2023 | -0.19 | -0.27 | 29.63% | $82.00K |
| Aug 8, 2023 | -0.28 | -0.26 | -7.69% | – | |
| May 11, 2023 | -0.27 | -0.27 | 0.00% | – | |
| Mar 1, 2023 | -0.27 | -0.22 | -22.73% | – | |
| Nov 9, 2022 | -0.28 | -0.23 | -21.74% | – | |
| Aug 8, 2022 | -0.24 | -0.24 | 0.00% | – | |
| May 10, 2022 | -0.26 | -0.22 | -18.18% | – | |
| Mar 1, 2022 | -0.23 | -0.21 | -9.52% | – | |
| Dec 30, 2021 | -0.22 | -0.20 | -10.00% | – |
- IBRX beat EPS estimates in 23 of its last 45 reports.
Updated 2026-11-07 11:55 UTC